Page last updated: 2024-10-27

gentamicin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

gentamicin has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornetta, K1
Moore, A1
Leemhuis, T1
Moen, RC1
Tricot, G1
Leibowitz, D1
Hoffman, R1
Cantin, A1
Woods, DE1

Other Studies

2 other studies available for gentamicin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Retroviral mediated gene transfer in chronic myelogenous leukaemia.
    British journal of haematology, 1994, Volume: 87, Issue:2

    Topics: Base Sequence; Cytokines; Drug Resistance; Gene Transfer Techniques; Genetic Vectors; Gentamicins; H

1994
Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.
    The Journal of clinical investigation, 1993, Volume: 91, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Catalase; Cats; Ceftazidime; Cell Survival; Dose-Response Relationsh

1993